Hospital Quironsalud Barcelona, NEXT Oncology

Barcelona 08023

0 studies enrolling now · 3 studies all time

What they study most

Metastatic or Locally Advanced Unresectable Solid Tumors, Solid Tumor, Adult, Unresectable Locally Advanced or Metastatic Cancer

Studies at this site

• First-in-Human Study of TAK-280 in Participants With Solid Tumors — Stopped early
• Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) — Running, not enrolling
• Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors — Status unconfirmed